Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers

This publication has 11 references indexed in Scilit:

• Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1993
• A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
  Cancer, 1992
• Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines
  JNCI Journal of the National Cancer Institute, 1990
• Phase I study of oxaliplatin in patients with advanced cancer
  Cancer Chemotherapy and Pharmacology, 1990
• Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data
  Biomedicine & Pharmacotherapy, 1989
• Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum
  Biomedicine & Pharmacotherapy, 1989
• The determination of platinum in biological materials by electrothermal atomic absorption spectroscopy
  Spectrochimica Acta Part B: Atomic Spectroscopy, 1987
• Differences in binding of (1,2-cyclohexanediamine)platinum(II) isomers with d(GpG)
  Inorganic Chemistry, 1986
• The crystal structures and absolute configurations of the anti-tumor complexes Pt(oxalato)(1R,2R-cyclohexanediamine) and Pt(malonato)(1R,2R-cyclohexanediamine)
  Inorganica Chimica Acta, 1984
• Relation of conformation to antitumor activity of platinum(II) complexes of 1,2-cyclohexanediamine and 2-(aminomethyl)cyclohexylamine isomers against leukemia P388
  Journal of Medicinal Chemistry, 1981